1Y Annualised Return
▲32.89%
3Y Annualised Return
▲68.23%
5Y Annualised Return
▲100.87%
Sanjivani Paranteral SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹77,00,442 (+18.47%)
Daily SIP of ₹25,000 would have become ₹77,00,442 in 1 year with a gain of ₹12,00,442 (+18.47%)
Sanjivani Paranteral Stock Performance
Today’s Low - High
223.05
237.95
223.05
237.95
52 Week Low - High
171.50
396.95
171.50
396.95
Open
225.05
Prev. Close
232.95
Volume
3,538.00
Total Traded Value
8.14 L
Sanjivani Paranteral Fundamental
Market Cap (in crs)
273.34
Face Value
10
Turnover (in lacs)
8.14
Key Metrics
Qtr Change %
42.05% Fall from 52W High
-9.7
Dividend yield 1yr %
0
Sanjivani Paranteral Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Sanjivani Paranteral Quarterly Revenue
| Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
18.18 Cr | 17.35 Cr | 18.13 Cr | 16.44 Cr | 12.86 Cr |
Sanjivani Paranteral Yearly Revenue
| Mar 2025 |
|---|
71.31 Cr |
Sanjivani Paranteral Quarterly Net Profit/Loss
| Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
2.19 Cr | 1.9 Cr | 2.3 Cr | 1.71 Cr | 1.26 Cr |
Sanjivani Paranteral Yearly Net Profit/Loss
| Mar 2025 |
|---|
8.09 Cr |
Sanjivani Paranteral Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
234.8
Current Price
5Day EMA
235.50
10Day EMA
237.80
12Day EMA
237.90
20Day EMA
237.40
26Day EMA
237.60
50Day EMA
243.00
100Day EMA
257.60
200Day EMA
260.80
5Day SMA
236.60
10Day SMA
242.00
20Day SMA
234.80
30Day SMA
233.30
50Day SMA
237.50
100Day SMA
264.40
150Day SMA
286.20
200Day SMA
290.60
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 2523 Rs | 3538 Rs |
Week Rs | 5782 Rs | 7575 Rs |
Month Rs | 6136 Rs | 7840 Rs |
Resistance & Support
230.35
Pivot
Resistance
First Resistance
237.65
Second Resistance
245.25
Third Resistance
252.55
Support
First Support
222.75
Second support
215.45
Third Support
207.85
Relative Strength Index
42.75
Money Flow Index
46.76
MACD
0.29
MACD Signal
0.86
Average True Range
14.56
Average Directional Index
12.85
Rate of Change (21)
-0.30
Rate of Change (125)
-32.88
Similar stocks
Similar Stocks
Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | 287.02 | 49.2 | 133 | 52.93 | 0.08% | -7.13% | -37.44% | -58.11% | -25.13% | 0.00% | 79.98 | 42.57 | 2.24 | |
- | 278.64 | 34.11 | 77.7 | 36.74 | 1.34% | -1.78% | -43.30% | -19.18% | 12.40% | 0.00% | 36.36 | 42.57 | 5.75 | |
- | 214.24 | 570 | 999 | 595.65 | -2.10% | -13.43% | -24.39% | 1.25% | 144.94% | 0.00% | 8.66 | 42.57 | 1.06 | |
- | 238.07 | 164 | 274.75 | 236.05 | -3.90% | 14.07% | 0.00% | 0.00% | 0.00% | 0.00% | 35.44 | 42.57 | 1.43 | |
- | 235.57 | 35.1 | 58.39 | 47.56 | 4.82% | 30.27% | 4.73% | -11.33% | 44.74% | 0.00% | 24.53 | 42.57 | 23.65 | |
- | 295.68 | 11.15 | 29 | 13.08 | -1.66% | -0.38% | -26.43% | -21.31% | 100.31% | 0.00% | 20.97 | 42.57 | 1.65 |
Sanjivani Paranteral Company background
Founded in: 1994
Managing director: Ashwin Khemka
Sanjivani Paranteral Ltd is a WHOGMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning twoandahalfdecades. The Company primarily focus on lifesaving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHOGMP certified manufacturing facilities in Mumbai and Dehradun.Incorporated as a public limited company in Oct.94, Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry. The Company has been involved in the manufacturing of pharmaceutical medicines. The Companys products includes oral solids, small volume parenteral and sterile powder formulations.The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade antibiotics and life saving injectibles used in various infections, pre and postoperative. The installed capacities for its products will be, 150 lac pa each for liquid vials and powder vials and 73 lac pa for its ampoules, taking the total capacity to 375 lac pa. The company came out with a public issue in Jan.96 to partfinance the project.The promoters have received firm inquiries from reputed pharmaceutical companies like Merind, Lupin Laboratories and USV for the first year production of liquid vials and ampules.During the year 199899, the Company has been approved by the WHO GMP Certificate. The Company is hoping for export of its products in Africa, Europe Latin America. The Company has also tied up with Cadila Ltd., Alkem Ltd., Indian Immunologicals Ltd for marketing its products.During the year 19992000, the company has tiedup with Indias first ranked pharmaceutical giant Ranbaxy for manufacturing its products.During 2009, the Company acquired a new pharmaceutical manufacturing plant in Uttarakhand.
As of 13 Jun, 2025, SANJIVIN share price is ₹230. The stock opened at ₹225 and had closed at ₹233 the previous day. During today’s trading session, SANJIVIN share price moved between ₹223.05 and ₹237.95, with an average price for the day of ₹230.00. Over the last 52 weeks, the stock has recorded a low of ₹171.50 and a high of ₹396.95. In terms of performance, SANJIVIN share price has declined by 31.2% over the past six months and has increased by 32.89% over the last year.
Sanjivani Paranteral FAQs
How to buy Sanjivani Paranteral shares?
You can easily buy Sanjivani Paranteral shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Sanjivani Paranteral stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account